{"id":4591,"date":"2024-01-30T13:14:50","date_gmt":"2024-01-30T13:14:50","guid":{"rendered":"https:\/\/cms.alj3.clients.lemonhq.io\/press-release\/majority-stake-in-genpharm-acquisition-6\/"},"modified":"2026-07-20T11:16:44","modified_gmt":"2026-07-20T11:16:44","slug":"majority-stake-in-genpharm-acquisition","status":"publish","type":"pressrelease","link":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/","title":{"rendered":"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu"},"content":{"rendered":"\n<p>(L-R) Kamel Ghammachi, Chairman &amp; Co-Founder, Genpharm; Akram Bouchenaki, Chief Executive Officer, Abdul Latif Jameel Health and Karim Smaira, Chief Executive Officer &amp; Co-Founder, Genpharm<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bu sat\u0131n al\u0131m, b\u00f6lgenin sa\u011fl\u0131k ve nadir hastal\u0131k sekt\u00f6r\u00fc i\u00e7in \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131na i\u015faret ediyor.<\/li>\n\n\n\n<li>Genpharm, nadir hastal\u0131k ve \u00f6zel ila\u00e7lar alan\u0131nda Orta Do\u011fu, Kuzey Afrika, T\u00fcrkiye ve \u00f6tesine a\u00e7\u0131lmak isteyen \u015firketlere h\u0131zl\u0131 pazar eri\u015fimi sa\u011flar. Genel merkezi BAE\u2019de bulunan ve b\u00f6lgede bilimsel ofisleri bulunan Genpharm, 80\u2019den fazla \u00e7al\u0131\u015fan istihdam etmektedir.<\/li>\n\n\n\n<li>2020 y\u0131l\u0131nda kurulan Abdul Latif Jameel Health, modern t\u0131bbi hizmetlere eri\u015fimde var olan e\u015fitsizlikleri gidermek i\u00e7in kuruldu. Birincil amac\u0131, geli\u015fmekte olan \u00fclkeler genelinde sa\u011fl\u0131k hizmetine kat\u0131l\u0131m\u0131 h\u0131zland\u0131rmakt\u0131r.<\/li>\n<\/ul>\n\n\n\n<p><strong>Dubai, BAE; [30 Ocak]:<\/strong> Uluslararas\u0131 \u00e7apta \u00e7e\u015fitli sekt\u00f6rlerde faaliyet g\u00f6steren yakla\u015f\u0131k 80 y\u0131ll\u0131k bir \u015firket olan <a href=\"https:\/\/www.alj.com\/tr\/\">Abdul Latif Jameel<\/a>\u2019in bir par\u00e7as\u0131 olan Abdul Latif <a href=\"https:\/\/aljhealth.com\/home\">Jameel Health<\/a>, bug\u00fcn Orta Do\u011fu, Kuzey Afrika ve T\u00fcrkiye\u2019de nadir hastal\u0131klar pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan <a href=\"https:\/\/www.genpharmservices.com\/\">Genpharm<\/a>\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu.<\/p>\n\n\n\n<p>Bu anla\u015fma, hastalara \u00f6ncelik vermek, sa\u011fl\u0131k hizmetlerinde kapsay\u0131c\u0131l\u0131\u011f\u0131 te\u015fvik etmek ve en \u00e7ok ihtiya\u00e7 duyanlar i\u00e7in modern t\u0131bbi hizmetlere eri\u015fimi h\u0131zland\u0131rmak i\u00e7in birlikte \u00e7al\u0131\u015fan bu iki i\u015fletme i\u00e7in de \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131na i\u015faret ediyor.<\/p>\n\n\n\n<p>K\u0131sa s\u00fcre \u00f6nce 12. y\u0131l d\u00f6n\u00fcm\u00fcn\u00fc kutlayan Genpharm, kan\u0131ta dayal\u0131 ila\u00e7lara ve en y\u00fcksek etik standartlar\u0131 korumaya kararl\u0131 bir ba\u011fl\u0131l\u0131kla 2012 y\u0131l\u0131nda kuruldu. B\u00f6lgeye, gen tedavisi konusunda uzmanl\u0131k kazand\u0131ran ilk \u00f6nc\u00fc b\u00f6lgesel \u015firketlerden biri olmaktan gurur duymaktad\u0131r. Genpharm ayr\u0131ca \u00e7ok \u00e7e\u015fitli nadir genetik hastal\u0131k, yetim ila\u00e7lar ve \u00f6zel terap\u00f6tikler i\u00e7in tercih edilen ticari ortakt\u0131r. B\u00f6lge ve \u00e7ok uluslu kurulu\u015flar hakk\u0131nda \u00e7ok y\u00f6nl\u00fc bir ge\u00e7mi\u015fe sahip deneyimli \u00fcst d\u00fczey ila\u00e7 sekt\u00f6r\u00fc y\u00f6neticileri taraf\u0131ndan idare edilen Genpharm, i\u015f ortaklar\u0131na hastal\u0131k alanlar\u0131, \u00fcr\u00fcn lansmanlar\u0131 ve pazara a\u00e7\u0131lma stratejileri hakk\u0131nda stratejik tavsiyeler de sa\u011flamaktad\u0131r.<\/p>\n\n\n\n<p>Kurucu ortaklar, \u0130cra Kurulu Ba\u015fkan\u0131 <a href=\"https:\/\/www.genpharmservices.com\/who-we-are\/management\/\">Karim Smaira<\/a> ve Ticaret Direkt\u00f6r\u00fc <a href=\"https:\/\/www.genpharmservices.com\/message-from-founders\/\">Kamel Ghammachi<\/a>, ortak bir a\u00e7\u0131klamada \u015funlar\u0131 ifade etti:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>\u201c2012 y\u0131l\u0131nda Genpharm\u2019\u0131 kurdu\u011fumuzda, bunu bir miras yaratmak ve \u00e7ocuklar\u0131m\u0131zla payla\u015fmaktan gurur duyaca\u011f\u0131m\u0131z bir \u015fey yaratmak amac\u0131yla yapt\u0131k. Global ila\u00e7 piyasas\u0131ndaki birlikte edindi\u011fimiz \u00f6nemli deneyimlerden Orta Do\u011fu genelinde nadir hastal\u0131k hastalar\u0131n\u0131n ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamada b\u00fcy\u00fck bir bo\u015fluk oldu\u011funu biliyorduk.<\/p>\n\n\n\n<p>\u201cHer zaman hastalara \u00f6ncelik vermek, yapt\u0131klar\u0131m\u0131z konusunda tutkulu olmak ve vaatlerimizi yerine getirmek \u015feklinde s\u0131ralayabilece\u011fimiz de\u011ferlerimiz, Abdul Latif Jameel Health\u2019in modern t\u0131bbi bak\u0131ma eri\u015fimi h\u0131zland\u0131rma misyonu ile tamamen uyumludur.<\/p>\n\n\n\n<p>B\u00f6lgenin en sayg\u0131n \u015firketlerinden biri olan Abdul Latif Jameel\u2019in deste\u011fiyle bir kurulu\u015fa kat\u0131lmak, MENA b\u00f6lgesindeki hastalara tedavi sunma konusundaki taahh\u00fctlerini vurgulamak i\u00e7in inan\u0131lmaz derecede s\u0131k\u0131 \u00e7al\u0131\u015fan \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n geli\u015fimini ve ilerlemesini sa\u011flarken, ayn\u0131 zamanda daha fazlas\u0131n\u0131 yapabilece\u011fimiz, daha fazla ki\u015fiye ula\u015fabilece\u011fimiz ve yard\u0131mc\u0131 olabilece\u011fimiz anlam\u0131na gelir. Birlikte ba\u015farmak ve miras\u0131m\u0131z\u0131 g\u00fc\u00e7lendirmeye devam etmek i\u00e7in Abdul Latif Jameel Health ile birlikte \u00e7al\u0131\u015fmay\u0131 sab\u0131rs\u0131zl\u0131kla bekliyoruz.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p>Abdul Latif Jameel Health, \u0130cra Kurulu Ba\u015fkan\u0131, <a href=\"https:\/\/aljhealth.com\/en\/our-people\/akram-bouchenaki\/\">Akram Bouchenaki<\/a>, \u015funlar\u0131 s\u00f6yledi:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201c<\/em>Genpharm\u2019\u0131n b\u00f6lgedeki sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn bu \u00f6nemli alan\u0131ndaki ba\u015far\u0131lar\u0131ndan inan\u0131lmaz derecede etkilendik. Son on y\u0131lda Karim ve Kamel, ekiplerinin nadir hastal\u0131klar i\u00e7in az say\u0131da ki\u015finin ilgilendi\u011fi terap\u00f6tik \u00fcr\u00fcnler sunmaya odaklanmas\u0131na ve b\u00f6lgedeki hastalara yenilik\u00e7i re\u00e7eteler ve tedaviler sa\u011flayan gen terapisinin sunulmas\u0131nda \u00f6nc\u00fc olmalar\u0131na liderlik etti. Bizi Genpharm\u2019a \u00e7eken \u015fey, en \u00e7ok ihtiyac\u0131 olanlar\u0131n t\u0131bbi bak\u0131ma eri\u015fimini h\u0131zland\u0131rmak i\u00e7in teknolojiden ve yenilik\u00e7i yakla\u015f\u0131mlardan yararlanma misyonumuzla uyumlu olan bu yenilik ve motivasyondur.\u201d<\/p>\n<\/blockquote>\n\n\n\n<p>Abdul Latif Jameel Health, Genpharm\u2019\u0131 stratejik olarak sat\u0131n ald\u0131ktan sonra Karim Smaira ve Kamel Ghammachi\u2019nin CEO ve Y\u00f6netim Kurulu Ba\u015fkan\u0131 olarak g\u00f6revlerine devam etmesini sa\u011flayarak mevcut y\u00f6netici yap\u0131s\u0131n\u0131 koruyacakt\u0131r. Ayr\u0131ca Akram Bouchenaki, Genpharm Y\u00f6netim Kurulunda yeni bir role ge\u00e7erek \u015firketin stratejik y\u00f6netimini daha da g\u00fc\u00e7lendirecek.<\/p>\n\n\n\n<p>Abdul Latif Jameel Health, modern t\u0131bbi hizmetlere eri\u015fimde devam eden k\u00fcresel e\u015fitsizli\u011fe bir yan\u0131t olarak 2020 y\u0131l\u0131nda ortaya \u00e7\u0131km\u0131\u015ft\u0131r ve d\u00fcnyan\u0131n daha az geli\u015fmi\u015f b\u00f6lgelerinde modern sa\u011fl\u0131k hizmetlerine eri\u015fimi ve kat\u0131l\u0131m\u0131 h\u0131zland\u0131rmaya odaklanmaktad\u0131r. Jameel Ailesinin daha iyi bir gelecek i\u00e7in yenilik yapmaya olan k\u00f6kl\u00fc ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 yans\u0131tan Abdul Latif Jameel Health, ger\u00e7ek d\u00fcnyadaki g\u00fcn\u00fcm\u00fcz\u00fcn somut ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamak i\u00e7in daha g\u00fczel bir gelecek yaratmak amac\u0131yla ticari ortamda faaliyetlerde bulunmaktad\u0131r. Mevcut \u00e7\u00f6z\u00fcmlerin da\u011f\u0131t\u0131m\u0131 ve MedTech\u2019in gelece\u011fine yat\u0131r\u0131m yapmak i\u00e7in yeni pazarlar\u0131 a\u00e7mak ve b\u00fcy\u00fctmek \u00fczere d\u00fcnyan\u0131n d\u00f6rt bir yan\u0131ndan i\u015f ortaklar\u0131yla birlikte \u00e7al\u0131\u015f\u0131r.<\/p>\n","protected":false},"featured_media":4571,"menu_order":0,"template":"","class_list":["post-4591","pressrelease","type-pressrelease","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel\" \/>\n<meta property=\"og:description\" content=\"(L-R) Kamel Ghammachi, Chairman &amp; Co-Founder, Genpharm; Akram Bouchenaki, Chief Executive Officer, Abdul Latif Jameel Health and Karim Smaira, Chief Executive Officer &amp; Co-Founder, Genpharm Dubai, BAE; [30 Ocak]: Uluslararas\u0131 \u00e7apta \u00e7e\u015fitli sekt\u00f6rlerde faaliyet g\u00f6steren yakla\u015f\u0131k 80 y\u0131ll\u0131k bir \u015firket olan Abdul Latif Jameel\u2019in bir par\u00e7as\u0131 olan Abdul Latif Jameel Health, bug\u00fcn Orta Do\u011fu, Kuzey [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-20T11:16:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1738\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/\",\"url\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/\",\"name\":\"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel\",\"isPartOf\":{\"@id\":\"https:\/\/10.0.2.131\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"datePublished\":\"2024-01-30T13:14:50+00:00\",\"dateModified\":\"2026-07-20T11:16:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage\",\"url\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"contentUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg\",\"width\":2560,\"height\":1738},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/10.0.2.131\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/10.0.2.131\/en\/#website\",\"url\":\"https:\/\/10.0.2.131\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/10.0.2.131\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"tr_TR","og_type":"article","og_title":"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel","og_description":"(L-R) Kamel Ghammachi, Chairman &amp; Co-Founder, Genpharm; Akram Bouchenaki, Chief Executive Officer, Abdul Latif Jameel Health and Karim Smaira, Chief Executive Officer &amp; Co-Founder, Genpharm Dubai, BAE; [30 Ocak]: Uluslararas\u0131 \u00e7apta \u00e7e\u015fitli sekt\u00f6rlerde faaliyet g\u00f6steren yakla\u015f\u0131k 80 y\u0131ll\u0131k bir \u015firket olan Abdul Latif Jameel\u2019in bir par\u00e7as\u0131 olan Abdul Latif Jameel Health, bug\u00fcn Orta Do\u011fu, Kuzey [&hellip;]","og_url":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/","og_site_name":"Abdul Latif Jameel","article_modified_time":"2026-07-20T11:16:44+00:00","og_image":[{"width":2560,"height":1738,"url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tahmini okuma s\u00fcresi":"3 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/","url":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/","name":"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu - Abdul Latif Jameel","isPartOf":{"@id":"https:\/\/10.0.2.131\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage"},"image":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","datePublished":"2024-01-30T13:14:50+00:00","dateModified":"2026-07-20T11:16:44+00:00","breadcrumb":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#primaryimage","url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","contentUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Genpharm_Press_release_Photo-scaled-1.jpg","width":2560,"height":1738},{"@type":"BreadcrumbList","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/news\/majority-stake-in-genpharm-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/10.0.2.131\/en\/"},{"@type":"ListItem","position":2,"name":"Abdul Latif Jameel Health, Orta Do\u011fu\u2019daki nadir hastal\u0131k pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu"}]},{"@type":"WebSite","@id":"https:\/\/10.0.2.131\/en\/#website","url":"https:\/\/10.0.2.131\/en\/","name":"Abdul Latif Jameel","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/10.0.2.131\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"}]}},"post-meta-fields":{"_published_date":["field_6057129b493f5"],"published_date":["20240130"],"_location":["field_601267396ce72"],"location":["Dubai, BAE"],"_featured":["field_601a3b473c5c5"],"featured":["1"],"_footnotes":["field_66fd39afb9383"],"footnotes":[""],"_business_sector":["field_66f6b5bcac8cb"],"business_sector":[false],"_content_series":["field_66fe3c439f8f6"],"content_series":[""],"_old_post_id":["field_66fe3fd59f8f7"],"old_post_id":["114122"],"_short_title":["field_60925d67125ef"],"short_title":["Genpharm'\u0131n Sat\u0131n Al\u0131nmas\u0131ndaki \u00c7o\u011funluk Hissesi"],"_summary":["field_6019304103a20"],"summary":["Uluslararas\u0131 \u00e7apta \u00e7e\u015fitli sekt\u00f6rlerde faaliyet g\u00f6steren yakla\u015f\u0131k 80 y\u0131ll\u0131k bir \u015firket olan Abdul Latif Jameel\u2019in bir par\u00e7as\u0131 olan Abdul Latif Jameel Health, bug\u00fcn Orta Do\u011fu, Kuzey Afrika ve T\u00fcrkiye\u2019de nadir hastal\u0131klar pazar\u0131na eri\u015fimde \u00f6nde gelen bir ortak olan Genpharm\u2019\u0131n \u00e7o\u011funluk hisselerini stratejik olarak sat\u0131n al\u0131nd\u0131\u011f\u0131n\u0131 duyurdu."],"_mobile_featured_image":["field_66f6b4bee65f3"],"mobile_featured_image":["https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Untitled-1-1.jpg"],"_push_notification":["field_66f6b47de65f1"],"push_notification":[""],"_publish_mobile":["field_66f6b491e65f2"],"publish_mobile":["1"],"_status":["field_652694983fe12"],"status":["private"],"_thumbnail_id":["4571"],"_wp_page_template":["default"],"_last_translation_edit_mode":["native-editor"],"select_category":["international"],"_edit_lock":["1784547716:22"],"_edit_last":["22"],"_select_category":["field_6937c5cade1ee"],"_ame_cpe_post_policy":["{\"accessProtection\":{\"active\":\"replace\"}}"],"_wpml_media_duplicate":["1"],"_wpml_media_featured":["1"],"_yoast_wpseo_content_score":["30"],"_yoast_wpseo_estimated-reading-time-minutes":["3"]},"_links":{"self":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/wp-json\/wp\/v2\/pressrelease\/4591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/wp-json\/wp\/v2\/pressrelease"}],"about":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/wp-json\/wp\/v2\/types\/pressrelease"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/wp-json\/wp\/v2\/media\/4571"}],"wp:attachment":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/tr\/wp-json\/wp\/v2\/media?parent=4591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}